Clinical Trials Logo

Postoperative Pain clinical trials

View clinical trials related to Postoperative Pain.

Filter by:

NCT ID: NCT03623399 Recruiting - Postoperative Pain Clinical Trials

Laparoscopic Gas Pressure and Postoperative Pain Score

Start date: August 7, 2018
Phase: N/A
Study type: Interventional

Aim of the study is to determine the effect of different laparoscopic intraoperative intraabdominal gas (CO2) pressures on the extent of postoperative pain scores.

NCT ID: NCT03622489 Recruiting - Postoperative Pain Clinical Trials

Comparing Protocols for Analgesia Following Elective Cesarean Section

Start date: March 1, 2017
Phase: Phase 4
Study type: Interventional

Women undergoing elective cesarian section will be assigned to 3 groups for postoperative analgesia: 1. Scheduled doses of IV acetaminophen + PO Ibuprofen 2. Scheduled doses of PO acetaminophen + PO Ibuprofen 3. "On demand" doses of acetaminophen, dipyrone and ibuprofen.

NCT ID: NCT03604068 Recruiting - Postoperative Pain Clinical Trials

Pulsed Short Wave Therapy In Cesarean Section

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following Cesarean section. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

NCT ID: NCT03602664 Recruiting - Postoperative Pain Clinical Trials

Postoperative Recovery After Thoracic Surgery

POLO
Start date: June 5, 2018
Phase:
Study type: Observational

A questionaire specifically developed using in depth interviews with patients that has undergone surgery has been developed. This questionaire will be used for longterm follow in patients undergoing thoracic surgery. 200 patients will be asked to fill in this questionaire preoperatively as well as 3 and 12 months after surgery to assess symptomburden after surgery with specific aim to study postoperative pain as well as other physical, mental and cognitive problems that may affect the patient and their daily activities, health, return to work, family life and economy.

NCT ID: NCT03596424 Recruiting - Postoperative Pain Clinical Trials

Dexmedetomidine and Ketamine in VATS Surgery

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Postoperative pain after VATS surgery is significant and associated with moderate to high post operative morphine requirements, which can cause opioid related side effects and delay postoperative recovery. To reduce this requirement, multimodal analgesia with non opioid medication such as dexmedetomidine and ketamine can be used. These drugs have demonstrated significant opioid-sparing properties after various types of surgeries. However, very little is known about their ability to do so in VATS surgery. Also, their relative opioid-sparing properties have not been compared, and it is not known whether their combined use can lead to an additional opioid-sparing effect. The primary goal of this study will be to determine the impact of a combined intra operative infusion of ketamine and dexmedetomidine on postoperative morphine requirements in patients undergoing elective VATS, compared to both these drugs infused separately. The hypothesis is that this combined infusion will lead to a 30% further reduction in morphine requirements, 24h after surgery, compared to both these drugs infused separately.

NCT ID: NCT03549221 Recruiting - Postoperative Pain Clinical Trials

Efficacy of Adrenaline in Periarticular Analgesic Injection on Postoperative Pain Control After Total Knee Arthroplasty

Start date: January 26, 2018
Phase: Phase 2
Study type: Interventional

Multimodal anesthetic drug injection has been used extensively and the results of many studies suggest that postoperative pain can relief and improve the postoperative satisfaction of patients. Adrenaline is a combination of multimodal anesthetic cocktail to relieve pain. It is believed that Adrenaline causes vasoconstriction, reduces absorption of anesthetic drug into the system circulation. Currently, a comparative study on the effect of pain reduction of Adrenaline injection in the anesthetic cocktail is relatively low. There are different doses in each institution. In addition, the use of new anesthetic is Levobupivacaine that has more vasoconstrictive effect compare with traditional Bupivacaine. It also reduces the side effects of systemic and cardiotoxic effect. Therefore, the investigators think that It may not be necessary to mix Adrenaline in the multimodal anesthetic drug. Levobupivacaine already to avoid the potential side effects of Adrenaline.

NCT ID: NCT03489499 Recruiting - Postoperative Pain Clinical Trials

Genetic Variants and Postoperative Pain

Start date: January 2011
Phase:
Study type: Observational

Prospective observational study to analyse patients' pain related outcome after surgery and ist association to genetic variants and non-genetic variables.

NCT ID: NCT03413371 Recruiting - Postoperative Pain Clinical Trials

Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)

PBBVRS
Start date: April 26, 2018
Phase: N/A
Study type: Interventional

The aim of this randomized trial is to assess the efficacy of preventive analgesia using different peribulbar blocks (PBB) under SPI-guided anaesthesia for vitreoretinal surgery (VRS), presence of PONV (postoperative nausea and vomiting) and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients will receive general anaesthesia combined with either preventive PBB using either lidocaine with bupivacaine or bupivacaine or ropivacaine

NCT ID: NCT03382938 Recruiting - Postoperative Pain Clinical Trials

Dexmedetomidine Wound Infiltration in Cesarean Section

Start date: August 23, 2019
Phase: N/A
Study type: Interventional

The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).

NCT ID: NCT03339284 Recruiting - Postoperative Pain Clinical Trials

QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery

Start date: December 4, 2017
Phase: Phase 4
Study type: Interventional

There are ca 900 new cases of kidney cancer in Finland/year. The curative therapy for kidney cancer is partial or total nephrectomy depending on the localization and the size of tumor. Main of these operations are laparoscopic. Epidural analgesia is considered as most effective for the treatment of postoperative pain after open nephrectomy, but after laparoscopic operation parenteral and enteral opioids combined with paracetamol (acetaminophen) usually offer adequate postoperative pain relief. However, the need for opioids postoperatively may be high and side effects, such as sedation and nausea, are common. On the other hand epidural analgesia has some contraindications and risks for serious complications. Nevertheless, inadequately treated acute postoperative pain is considered as one of the main risk factors for persistent postoperative pain. Recently quadratus lumborum block (QLB) has gained popularity in the treatment of postoperative pain after various surgeries in the area from hip to mamilla. It is more beneficial than other peripheral blocks, since it covers also the visceral nerves. A single shot QLB has reported to last up to 48 hours. Perineural dexamethasone added to local anesthetic has been reported to prolong the duration of analgesia of the perineural nerve block, but it's effect on the duration of QLB is not known. 90 kidney cancer patients with planned laparoscopic nephrectomy aging 18-85 will be recruited based on a power calculation. The primary outcome measure is the postoperative cumulative opioid consumption. Secondary outcomes are acute pain (NRS scale), nausea, vomiting, mobilisation and long term outcomes such as quality of life and persistent pain.